Loading...

Home
Stock
NOVN.SW

NOVN.SW News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
News Release

Market

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

Strategies

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
CoinSwing
Daytrading Radar
Crypto Radar
Char Pattern Detection

Resource

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat with Tia
AI Screener
Backtesting Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Option Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
Seeking Alpha

NOVN.SW News

Novartis Highlights Groundbreaking Scientific Advances in Hematology and Oncology at ASH and SABCS

Nov 25 2025Yahoo Finance

Malaria Advancement Could Shift Investment Perspective on Novartis (SWX:NOVN)

Nov 20 2025Yahoo Finance

Novartis Unveils New Data at ASN Kidney Week and AHA Scientific Sessions Highlighting Progress in CRM Portfolio and Pipeline

Nov 04 2025Yahoo Finance

Novartis Claims 100% Tariff on Branded Pharmaceuticals Will Not Affect Them

Sep 26 2025Yahoo Finance

European pharmaceutical stocks decline as Trump warns of additional tariffs.

Sep 26 2025Yahoo Finance

Novartis and Monte Rosa Reach $5.7 Billion Agreement for Drug Development

Sep 15 2025Yahoo Finance

Novartis set to purchase Tourmaline Bio in a $1.4 billion agreement

Sep 09 2025Yahoo Finance

Novartis (NVS) Enhances Forecast Following Ianalumab Trial Success and Leqvio Growth

Aug 31 2025Yahoo Finance

NOVN.SW Events

an image of No data

No data

NOVN.SW Monitor News

an image of No data

No data

NOVN.SW Earnings Analysis

an image of No Data

No Data

People Also Watch